Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Prolocor
AddedFeb 15, 2024
UpdatedJun 18, 2026
Prolocor

Prolocor

Seed

Prolocor: A Philadelphia-based biotech firm innovating precise diagnostic tools for cardiovascular diseases.

HQ
Philadelphia, PA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Prolocor, founded in 2020 and based in Philadelphia, PA, is a biotechnology company dedicated to developing advanced diagnostic tests for cardiovascular diseases. The company's core mission is to create precise tools that can better assess and manage the risk of cardiovascular conditions, addressing a significant unmet need in the medical field. Prolocor focuses on innovating solutions that guide individualized therapy for patients, aiming to reduce the prevalence and impact of atherosclerotic cardiovascular disease.

Prolocor has garnered attention for its pioneering approach in the biotech industry. While specific notable affiliated people and investors are not mentioned, the company's achievements include the development of cutting-edge diagnostic methods that promise to transform cardiovascular disease management. By offering more accurate diagnostic tools, Prolocor aims to significantly improve patient outcomes and reduce mortality rates associated with cardiovascular diseases, making a substantial impact on public health.

Prolocor - Similar Companies

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Test Diagnostics logo

Test Diagnostics

Proteotech logo

Proteotech

Proxim Diagnostics logo

Proxim Diagnostics

proximdx.com

Probius logo

Probius

probius.bio

Prevencio logo

Prevencio

prevenciomed.com

Phoresa logo

Phoresa

Pointcare Genomics logo

Pointcare Genomics

Gregor Diagnostics logo

Gregor Diagnostics

HDL Diagnostics logo

HDL Diagnostics

ThromboVision logo

ThromboVision

Cardurion Pharmaceuticals logo

Cardurion Pharmaceuticals

Exactus logo

Exactus

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

Plasmonic Diagnostics logo

Plasmonic Diagnostics

Prolocor - Quick Facts

Who are Prolocor's competitors?

Companies similar to Prolocor include Prompt Diagnostics, Test Diagnostics, Proteotech and Proxim Diagnostics.

When was Prolocor founded?

Prolocor was founded in 2020.

Where is Prolocor's headquarters located?

Prolocor's headquarters is located in Philadelphia, PA, US.

When was Prolocor's last funding round?

Prolocor's most recent funding round was for $3.2M (USD) in August 2022.

How much has Prolocor raised to-date?

As of Aug 16, 2022, Prolocor has raised a total of $5.2M (USD).

How many employees does Prolocor have?

Prolocor has 6 employees as of Feb 5, 2024.

Prolocor - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostic Tests
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified